Alemtuzumab in relapsed or refractory chronic lymphocytic leukemia and prolymphocytic leukemia.
McCune SL, Gockerman JP, Moore JO, Decastro CM, Bass AJ, Chao NJ, Long GD, Vredenburgh JJ, Gasparetto C, Adams D, Payne N, Rizzieri DA.
McCune SL, et al. Among authors: rizzieri da.
Leuk Lymphoma. 2002 May;43(5):1007-11. doi: 10.1080/10428190290021597.
Leuk Lymphoma. 2002.
PMID: 12148879